News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Diagnostics Company Check Cap Cancels IPO


12/6/2010 8:27:57 AM

Globes -- The IPO of Check Cap, which has developed a capsule for locating polyps in the colon, has been cancelled, because the company failed to achieve a valuation of $70 million. Sources close to the company told "Globes" that the IPO could probably have taken place at a valuation of $55 million, but the company preferred to forego it and to use its cash, $5 million, to carry out a clinical trial that it believes will enable it to reach the desired valuation, not necessarily on the Tel Aviv Stock Exchange.

Read at Globes Online


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES